A phase III study of AZ01 for the treatment of relapsing‐remitting multiple sclerosis (RRMS)
Latest Information Update: 16 Apr 2016
At a glance
- Drugs Peginterferon beta (Primary)
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
Most Recent Events
- 15 Apr 2016 New trial record